GSK raises 2023 earnings guidance on strong second-quarter sales ...Middle East

GSK raised its full-year profit and sales guidance on Wednesday after its second-quarter earnings beat expectations, helped by strong sales of its shingles vaccine Shingrix and HIV medicines. The London-listed drugmaker now expects adjusted earnings per share growth of 14%-17% for the year, up from its earlier expectations of 12%-15%.

Hence then, the article about gsk raises 2023 earnings guidance on strong second quarter sales was published today ( Wednesday 26/07/2023 - 10:01 AM ) and is available on Devdiscourse ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( GSK raises 2023 earnings guidance on strong second-quarter sales )

Also on site :

• Historic Strike: Workers Demand Fairness at Colorado Meatpacking Giant
• Trump's Bold Statement: Aiming for Cuba
• United Arab Emirates lifts brief airspace closure over Iranian attacks, reports AP.